言語を選択

HLA-A*0201 & B2M & HBV (FLLTKILTI)

HLA-A*0201 & B2M & HBV (FLLTKILTI) 製品リスト

属性
Protein (2)
製品ライブラリ
オンライン (2)
種
Human (2)
タグ
His Tag & Avi Tag (2)
マーカー
Biotin-labeled (1)PE Labeled (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
HLT-H82E7	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Complex Protein (Monomer, MALS verified)
HLV-HP2E3	Human	HEK293	PE-Labeled Human HLA-A*02:01&B2M&HBV (FLLTKILTI) Tetramer Protein

総数量2

HLA-A*0201 & B2M & HBV (FLLTKILTI)バックグランド

Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). The hepatitis B virus attacks the liver and can cause both acute and chronic diseases that put people at high risk of death from cirrhosis and liver cancer. The virus is most commonly transmitted from mother to child during birth and delivery, as well as through contact with blood or other body fluids. Hepatitis B virus (HBV) is a member of the hepadnaviral family. The virus particle (virion) consists of an outer lipid envelope and an icosahedral nucleocapsid core composed of the core protein. The nucleocapsid encloses the viral DNA and a DNA polymerase that has reverse transcriptase activity. The outer envelope contains embedded proteins that are involved in viral binding of, and entry into, susceptible cells. The surface antigens (HBsAg) decorating the lipid envelope of HBV are produced in excess during the life cycle of the virus, and its presence in blood indicates current hepatitis B infection. The Human HLA-A*0201 HBV (FLLTKILTI) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and FLLTKILTI peptide of the HBV.

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
Ajulemic acid	HU-239; CPL-7075; CT-3; JBT-101; DMH-THC-11-OIC; DMH-11C; IP-751	Phase 3 Clinical	Corbus Pharmaceuticals Holdings Inc	Cystic Fibrosis; Lupus Vulgaris; Dermatomyositis; Lupus Erythematosus, Systemic; Scleroderma, Diffuse	詳細
Dronabinol(AXIM Biotechnologies)		Phase 3 Clinical	Axim Biotech	Neoplasms; Child Nutrition Disorders; Vomiting; Nausea; Cachexia; Sarcopenia; Anorexia Nervosa	詳細
Dronabinol（Vertanical）	VER-01	Phase 3 Clinical	Vertanical GmbH	Low Back Pain	詳細
cannabidiol (Cardiol Therapeutics)		Phase 3 Clinical	Cardiol Therapeutics Inc	Coronavirus Disease 2019 (COVID-19); Pericarditis; Cardiovascular Diseases; Myocarditis	詳細
RG-7774	RG-7774	Phase 2 Clinical	F. Hoffmann-La Roche Ag	Diabetic Retinopathy	詳細
ART-2713	NEO-1940; ART-2713; ART27.13; AZD-1940	Phase 2 Clinical	Astrazeneca Plc, Neomed Inc, Pfizer Inc	Weight Loss; Pain; Anorexia; Cachexia; Low Back Pain	詳細
Cannabidiol/hydroxychloroquine	IHL-675A; IHL-675	Phase 2 Clinical	Incannex Healthcare Ltd	Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult	詳細
Beta-Caryophyllene		Phase 2 Clinical	Hartford Hospital	Pain	詳細
CNTX-6016	CNTX-6016	Phase 1 Clinical	C.H. Boehringer Sohn Ag & Co. Kg	Pain; Chronic Pain; Diabetic Neuropathies; Nociceptive Pain	詳細
ZYN-001	ZYN-001	Phase 1 Clinical	Zynerba Pharmaceuticals	Neuralgia; Fibromyalgia	詳細
EHP-101	EHP-101; VCE-004; VCE-004.8	Phase 1 Clinical	Emerald, Vivacell Biotechnology	Multiple Sclerosis, Relapsing-Remitting; Scleroderma, Diffuse	詳細
IPI 201（Isosceles Pharmaceuticals Inc ）	IPI-201	Phase 1 Clinical		Pain, Postoperative	詳細
HU-308	PPP-003	Phase 1 Clinical	Panag Pharma	Pain; Retinal Diseases; Uveitis; Xerophthalmia; Ocular inflammation	詳細
NTRX-07	MDA7; NTRX-07; MDA-7	Phase 1 Clinical	The University Of Texas MD Anderson Cancer Center	Alzheimer Disease; Neuralgia	詳細
MP-10X	MP-10X	Clinical	Medipure Holdings	Pain	詳細
Cannabidiol/Palmitoylethanolamide	THX-210; SCI–210	Clinical	Therapix Biosciences Ltd	Autism Spectrum Disorder; Diabetic Neuropathies	詳細
C20T5	C20T5		Murdoch Childrens Research Institute		詳細
C12T12	C12T12		Murdoch Childrens Research Institute		詳細

市販薬剤に関する情報

英語名	研究コード	研究開発ステージ	会社	オリジナル製品名	最初に承認をした国	最初の適応症	最初に承認を受けた会社	承認された日付	適応症	臨床試験
Cannabidiol/Dronabinol	THC-5; delta-9-THC/CBD; MPL-001; MPL-005; GW-1000; KL16-012; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT	Approved	Gw Pharmaceuticals	Sativex, Qixleef	Canada	Muscle Spasticity; Neuralgia; Cancer Pain; Chronic Pain; Multiple Sclerosis	null	2005-04-01	Back Pain; Phobia, Social; Neuralgia, Postherpetic; Huntington Disease; Reflex Sympathetic Dystrophy; Tourette Syndrome; Muscle Spasticity; Malnutrition; Sciatica; Acute Pain; Neuromyelitis Optica; Arthritis, Psoriatic; Neuralgia; Dementia; Panic Disorder; Osteoarthritis, Knee; Hepatic Insufficiency; Stress Disorders, Post-Traumatic; Healthy Aging; Hidradenitis Suppurativa; Agoraphobia; Drug Resistant Epilepsy; Renal Insufficiency, Chronic; Social Behavior; Corticobasal degeneration; Cerebral Palsy; Low Back Pain; Neoplasms; Sleep Initiation and Maintenance Disorders; Peripheral Nervous System Diseases; Pain; Chronic Pain; Depression; Depressive Disorder, Major; Marijuana Abuse; Marijuana Use; Spasm; Squamous Cell Carcinoma of Head and Neck; Cancer Pain; Renal Insufficiency; Spinal Cord Injuries; Migraine Disorders; Arthritis, Rheumatoid; Neck Pain; Diabetic Neuropathies; Sleep Wake Disorders; Opioid-Related Disorders; Essential Tremor; Anorexia; Anxiety Disorders; Kidney Diseases; Multiple Sclerosis; Tic Dis	詳細
Cannabidiol	AVCN-583601; GLA-015; BTX-1503; BTX-1801; BTX-1702; LYT-310; RAD011; PBX-1308; RAD-011; BRCX-014; RLS-103; GWP-42003; GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; ZYN-002; PTL-101; CHI-902; APH-1501	Approved	Gw Pharmaceuticals Plc	Epidiolex, Epidyolex, Zygel, Cannepil	United States	Epilepsies, Myoclonic; Lennox Gastaut Syndrome	null	2018-06-25	Migraine Disorders; Peripheral Nervous System Diseases; Acne Vulgaris; HIV Infections; Tobacco Smoking; Ovarian Neoplasms; Sleep Initiation and Maintenance Disorders; Facial Pain; Substance-Related Disorders; Marijuana Smoking; Tobacco Use Cessation; Anxiety; Pain; Chronic Pain; Marijuana Use; Seizures; Tuberous Sclerosis; Rett Syndrome; Schizophrenia; Appetitive Behavior; Autism Spectrum Disorder; Marijuana Abuse; Brain Injuries, Traumatic; Depression; Alcoholic Intoxication; Inflammatory Bowel Diseases; Fatty Liver; Child Behavior Disorders; Diabetes Mellitus, Type 2; Spinal Cord Injuries; Sleep Wake Disorders; Anxiety Disorders; Neoplasms; Opioid-Related Disorders; Diabetic Neuropathies; Coronavirus Disease 2019 (COVID-19); Musculoskeletal Pain; Graft vs Host Disease; Blepharospasm; Dyspepsia; Arthritis, Rheumatoid; Psychotic Disorders; Hyperalgesia; Chronic Urticaria; Hoarding Disorder; Bipolar Disorder; Pancreatic Neoplasms; Brain Diseases; Dysmenorrhea; Sturge-Weber Syndrome; Lennox Gastaut Syndrome; Ph	詳細